Cargando…
CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia
Most clinical studies supporting procalcitonin (PCT)-guided management of lower respiratory tract infections have been performed in adults. There is a paucity of studies evaluating the clinical impact of PCT use in children and limited data informing age-appropriate PCT cut-offs; diagnostic accuracy...
Autor principal: | Banerjee, Ritu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531866/ https://www.ncbi.nlm.nih.gov/pubmed/34704032 http://dx.doi.org/10.1093/jacamr/dlab152 |
Ejemplares similares
-
Does procalcitonin have clinical utility in the management of paediatric community-acquired pneumonia? A PRO/CON debate
por: Chiotos, Kathleen, et al.
Publicado: (2021) -
Lung ultrasonography to diagnose community-acquired pneumonia in children
por: Principi, Nicola, et al.
Publicado: (2017) -
Role of procalcitonin in diagnosis of community acquired pneumonia in Children
por: Ratageri, Vinod H., et al.
Publicado: (2022) -
Does thrombo-aspiration still have a place in the treatment of myocardial infarction?
por: Schiele, François, et al.
Publicado: (2016) -
Debates in allergy medicine: Specific immunotherapy in children with atopic dermatitis, the “con” view
por: Ginsberg, David N., et al.
Publicado: (2016)